首页>
外国专利>
Stabilitats-, biokompatibilitats-optimiertes adjuvans (sba) zur erhohung der humoralen und zellularen immunantwort
Stabilitats-, biokompatibilitats-optimiertes adjuvans (sba) zur erhohung der humoralen und zellularen immunantwort
展开▼
机译:稳定性,生物相容性优化的佐剂(sba),可提高体液和细胞免疫反应
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to a stability and biocompatibility-optimized adjuvant (SBA) for enhancing the humoral and cellular immune response by jointly injecting said adjuvant with one or more antigens. The adjuvant consists of particles based on solid lipids or solid lipid mixtures and can be used in the production of more efficient and compatible vaccines, the inoculation of human beings and animals and for obtaining antibodies. The strength of the immune response can be modulated in a targeted manner and additionally adapted to the specific species by selecting the size, charge and surface characteristics of the particles. Other adjuvants, e.g. molecular adjuvants such as GMDP, can be added to the SBA, whereby the cellular immune response is additionally enhanced. The SBA is more effective and cost-efficient and easier to use than existing products and is well tolerated in vivo.
展开▼